v3.26.1
SHAREHOLDERS’ EQUITY (DEFICIT)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
SHAREHOLDERS’ EQUITY (DEFICIT) SHAREHOLDERS’ EQUITY (DEFICIT)
Shareholders’ Equity (Deficit)
As of March 31, 2026 there were 4,571,382 shares of our common stock outstanding and 12,000,000 shares authorized at $0.30 par value per share.
As of March 31, 2026 there were 75,000 shares of preferred stock outstanding, designated as Series B Preferred Stock, and we had 500,000 authorized shares at $100.00 par value per share of preferred stock (see Note 13 - Redeemable Preferred Stock for more detail).
Warrants
As of March 31, 2026, the Company had the following warrants issued and outstanding:
HolderIssuance dateNumber of warrants/ shares issuable Exercise priceExpiration date
APSC Holdco II, LP12/18/2020, 11/9/2021, 12/8/2021500,000 $15.00 12/8/2028
Corre and affiliates
12/8/2021500,000 $15.00 12/8/2028
Stellex Holder:
  Tranche A9/11/2025982,371 $23.00 9/11/2035
  Tranche B9/11/2025470,889 $50.00 9/11/2035
Total warrants2,453,260 
Accumulated Other Comprehensive Income (loss)
A summary of changes in accumulated other comprehensive loss included within shareholders’ equity (deficit) is as follows (in thousands):
 Three Months Ended
March 31, 2026		Three Months Ended
March 31, 2025
 (unaudited)(unaudited)
 Foreign
Currency
Translation
Adjustments		Defined Benefit Pension PlansTax
Provision		TotalForeign
Currency
Translation
Adjustments		Defined Benefit Pension PlansTax
Provision		Total
Balance, beginning of period
$(25,452)$(11,148)$(193)$(36,793)$(33,249)$(10,951)$71 $(44,129)
Other comprehensive income (loss)(1,606)118 (29)(1,517)2,015 95 (44)2,066 
Balance, end of period$(27,058)$(11,030)$(222)$(38,310)$(31,234)$(10,856)$27 $(42,063)